Normal view MARC view ISBD view

Benefits and harms of prostate cancer screening - predictions of the ONCOTYROL prostate cancer outcome and policy model. [electronic resource]

By:

Mühlberger, Nikolai

Contributor(s):

Producer: 20171213Description: 596 p. digitalISSN:

1471-2458

Subject(s):

Online resources:

Available from publisher's website

In: BMC public health vol. 17

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

21 Adjuvant systemic treatment of resectable breast cancer: eleven years results of a monoinstitutional chemo-hormone-immunotherapy trial.
by Rosso, R
22 [Merkel's tumor. Some comments and the authors' personal cases].
by Gipponi, M
23 Improved chopping of a lithium beam for plasma edge diagnostic at ASDEX Upgrade.
by Willensdorfer, M
24 [Role of interferon alfa-2 in melanoma. Results of a phase II study in 27 patients].
by Bernengo, M G
25 Continuous venous infusion of vinblastine in metastatic breast cancer.
by Pronzato, P
26 Carbon charge exchange analysis in the ITER-like wall environment.
by Menmuir, S
27 Radioimmunoimaging in malignant melanoma with monoclonal antibodies.
by Repetto, L
28 Preoperative chemotherapy and radiotherapy in the management of epidermoid carcinoma of the anal canal.
by Secco, G B
29 High-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors: a mechanism for post-bone marrow transplantation osteopenia.
by Banfi, A
30 Recombinant alpha interferon in the treatment of low-grade non-Hodgkin's lymphoma: results of a cooperative phase II trial in 31 patients.
by Mantovani, L
31 Surgical complications related to peri-operative adjuvant chemotherapy in breast cancer. Results of a prospective, controlled, randomized clinical trial.
by Canavese, G
32 Antitumoral activity of human fibroblast interferon administered intranodularly.
by Rosso, R
33 A pilot study of accelerated cyclophosphamide, epirubicin and 5-fluorouracil plus granulocyte colony stimulating factor as adjuvant therapy in early breast cancer.
by Del Mastro, L
34 Sentinel node biopsy in patients with cutaneous melanoma.
by Cafiero, F
35 Cisplatin, methotrexate, and 5-fluorouracil combination chemotherapy for advanced ovarian cancer.
by Conte, P F
36 Adjuvant post-operative radiotherapy vs radiotherapy plus 5-FU and levamisole in patients with TNM stage II-III resectable rectal cancer. A phase III randomized clinical trial. P.A.R. Cooperative Study Group.
by Cafiero, F
37 Impact of administration-related factors on outcome of adjuvant chemotherapy for primary breast cancer.
by Pronzato, P
38 Micronucleus analysis in peripheral blood lymphocytes from melanoma patients treated with dacarbazine.
by Miele, M
39 [Bacterial contamination of the stomach. Considerations on patients with duodenal ulcer treated with medical or surgical therapy].
by Cafiero, F
40 Impact of irradiation of residual breast on adjuvant chemotherapy dose intensity.
by Pronzato, P